Dcspka stated: ""Question: what is the real value/financial leverage RXPC has with Onko-Sure/DR-70 at this point in time? Any left?"
When the last patent expired, it then made all the value equal between Radient, UNI and GCDx. All of them have the technology and knowhow to manufacture DR70 and no one pays any royalty to anyone.
The Aussies now also have the technology so you might also put them on an equal level with UNI and GCDx.
As for CIT which you now claim has all the value, please explain why Radient stated the following:
"Due to the following conditions at December 31, 2010, we decided to impair the remaining balance of our CIT asset:
· Lack of any potential future revenue;
· Lack of future cash flows;
· High cost of future clinical studies; and
· Limited time remaining on the patent. "
I have never shorted nor intend to have any financial interest in this stock. I am not connected with anyone who trades, shorts or has financial interests in this stock. I only post facts and my opinions. I do not post on IHUB with different aliases.
